These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 24356282)
1. Rituximab in previously treated primary immune thrombocytopenia patients: evaluation of short- and long-term efficacy and safety. Santoro C; Biondo F; Baldacci E; De Propris MS; Guarini A; Paoloni F; Foà R; Mazzucconi MG Acta Haematol; 2014; 132(1):24-9. PubMed ID: 24356282 [TBL] [Abstract][Full Text] [Related]
2. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C; Reu FJ; Ho AD; Hensel M Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529 [TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia. Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Isola M; Buttignol S; Fanin R Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483 [TBL] [Abstract][Full Text] [Related]
4. Very long-term remission induced by short-term rituximab monotherapy in a patient with heavily pretreated, chronic immune thrombocytopenic purpura. Clausen MR; Segel E; Brandsborg M; d'Amore F Eur J Haematol; 2011 Mar; 86(3):256-9. PubMed ID: 21166717 [TBL] [Abstract][Full Text] [Related]
5. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature. Jovancevic B; Lindholm C; Pullerits R Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795 [TBL] [Abstract][Full Text] [Related]
8. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura]. Wang W; Yu QH; Zhang HY; Chu XX; Chen F; Zhang CQ; Zhou YH; Hou M Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508 [TBL] [Abstract][Full Text] [Related]
9. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170 [TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre. Besada E; Koldingsnes W; Nossent JC Rheumatology (Oxford); 2013 Nov; 52(11):2041-7. PubMed ID: 23934313 [TBL] [Abstract][Full Text] [Related]
11. B-cell compartment as the selective target for the treatment of immune thrombocytopenias. Zaja F; Vianelli N; Sperotto A; De Vita S; Iacona I; Zaccaria A; Masolini P; Tomadini V; Tani M; Molinari AL; Baccarani M; Fanin R Haematologica; 2003 May; 88(5):538-46. PubMed ID: 12745273 [TBL] [Abstract][Full Text] [Related]
12. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura. Zaja F; Battista ML; Pirrotta MT; Palmieri S; Montagna M; Vianelli N; Marin L; Cavallin M; Bocchia M; Defina M; Ippoliti M; Ferrara F; Patriarca F; Avanzini MA; Regazzi M; Baccarani M; Isola M; Soldano F; Fanin R Haematologica; 2008 Jun; 93(6):930-3. PubMed ID: 18403395 [TBL] [Abstract][Full Text] [Related]
13. Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results. Medeot M; Zaja F; Vianelli N; Battista M; Baccarani M; Patriarca F; Soldano F; Isola M; De Luca S; Fanin R Eur J Haematol; 2008 Sep; 81(3):165-9. PubMed ID: 18510702 [TBL] [Abstract][Full Text] [Related]
14. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus. Kumar S; Benseler SM; Kirby-Allen M; Silverman ED Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962 [TBL] [Abstract][Full Text] [Related]
15. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis. Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J; Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322 [TBL] [Abstract][Full Text] [Related]
16. Low-dose rituximab in adult patients with primary immune thrombocytopenia. Zaja F; Vianelli N; Volpetti S; Battista ML; Defina M; Palmieri S; Bocchia M; Medeot M; De Luca S; Ferrara F; Isola M; Baccarani M; Fanin R Eur J Haematol; 2010 Oct; 85(4):329-34. PubMed ID: 20546023 [TBL] [Abstract][Full Text] [Related]
17. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study. Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092 [TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy of lower dose rituximab for chronic refractory immune thrombocytopenic purpura]. Li Y; Wang XM; Mao M; Zhang XY; Fu L; Ai HM; Zhang LX Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):204-6. PubMed ID: 22781608 [TBL] [Abstract][Full Text] [Related]
19. [Clinical study of standard dose of rituximab for the treatment of refractory primary immune thrombocytopenia]. Zhu YC; Wang W; Zhou YH; Wang XM; Wang X; Wang YL; Sun GZ; Hou M Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):163-7. PubMed ID: 21535953 [TBL] [Abstract][Full Text] [Related]
20. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia. Cooper N; Stasi R; Cunningham-Rundles S; Cesarman E; McFarland JG; Bussel JB Br J Haematol; 2012 Aug; 158(4):539-47. PubMed ID: 22775462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]